The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients-Reference-Cited by-同舟云学术

The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients

Published:2020-01 Issue: Volume:292 Page:231-233
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Rallidis Loukianos S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

1. ESC committee for practice guidelines (CPG);Mach;ESC Nat. Card. Soc. Atheroscler.,2019

2. IMPROVE-IT investigators ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl. J. Med.,2015

3. FOURIER steering committee and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease;Sabatine;N. Engl. J. Med.,2017

4. ODYSSEY OUTCOMES committees and investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome;Schwartz;N. Engl. J. Med.,2018

5. Eligibility for treatment with PCSK9 inhibitors among patients with stable coronary artery disease presumed to be on maximum hypolipidaemic therapy;Rallidis;Hellenic J. Cardiol.,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PACMAN-AMI trial: a revolution in the treatment of acute coronary syndromes;European Heart Journal Supplements;2023-04-26

2. Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India;Journal of Clinical Lipidology;2023-03

3. Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment;Journal of Medicinal Chemistry;2022-11-29

4. Rationale and design of the Hellenic Registry of Clinical events and Adherence to Lipid LowerINg therapy In aCUte coronary Syndrome (CALLINICUS-Hellas Registry);Hellenic Journal of Cardiology;2022-07

5. Research Progress of Inclisiran;Advances in Clinical Medicine;2022